ESC Professional Premium Access

Panel discussion.

Congress Session

3 more presentations in this session

State of the art lecture - when is the time to implement novel biomarkers routinely?

Speaker: Professor B. Ference (Cambridge, GB)

Thumbnail

Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population

Speaker: Mr Z. Lu (Rotterdam, NL)

Thumbnail

Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover

Speaker: Doctor J. Melgarejo (Leuven, BE)

Thumbnail

Access the full session

When is the time to implement novel biomarkers routinely?

Speakers: Professor B. Ference, Mr Z. Lu, Doctor J. Melgarejo
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk